Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection.
Guinea pig cytomegalovirus (GPCMV) provides a valuable model for congenital cytomegalovirus transmission. Salivary gland (SG)-passaged stocks of GPCMV are pathogenic, while tissue culture (TC) passage in fibroblasts results in attenuation. Nonpathogenic TC-derived virus N13R10 (cloned as a bacterial artificial chromosome [BAC]) has a 4-bp deletion that disrupts GP129, which encodes a subunit of the GPCMV pentameric complex (PC) believed to govern viral entry into select cell types, and GP130, an overlapping open reading frame (ORF) of unknown function. To determine if this deletion contributes to attenuation of N13R10, markerless gene transfer in Escherichia coli was used to construct virus r129, a variant of N13R10 in which the 4-bp deletion is repaired. Virions from r129 were found to contain GP129 as well as two other PC subunit proteins, GP131 and GP133, whereas these three PC subunits were absent from N13R10 virions. Replication of r129 in fibroblasts appeared unaltered compared to that of N13R10. However, following experimental challenge of immunocompromised guinea pigs, r129 induced significant weight loss, longer duration of viremia, and dramatically higher (up to 1.5 × 10(6)-fold) viral loads in blood and end organs compared to N13R10. In pregnant guinea pigs, challenge with doses of r129 virus of ≥5 × 10(6) PFU resulted in levels of maternal viremia, congenital transmission, pup viral loads, intrauterine growth restriction, and pup mortality comparable to that induced by pathogenic SG virus, although higher doses of r129 were required. These results suggest that the GP129-GP130 mutation is a significant contributor to attenuation of N13R10, likely by abrogating expression of a functional PC.



Tissue culture adaptation of cytomegaloviruses rapidly selects for mutations, deletions, and rearrangements in the genome, particularly for viruses passaged in fibroblast cells. Some of these mutations are focused in the region of the genome encoding components of the pentameric complex (PC), in particular homologs of human cytomegalovirus (HCMV) proteins UL128, UL130, and UL131A. These mutations can attenuate the course of infection when the virus is reintroduced into animals for vaccine and pathogenesis studies. This study demonstrates that a deletion that arose during the process of tissue culture passage can be repaired, with subsequent restoration of pathogenicity, using BAC-based mutagenesis. Restoration of pathogenicity by repair of a frameshift mutation in GPCMV gene GP129 using this approach provides a valuable genetic platform for future studies using the guinea pig model of congenital CMV infection.
Department of Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Michael A
MA
McVoy
Department of Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Jian Ben
JB
Wang
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Dirk P
DP
Dittmer
Center for Infectious Diseases and Microbiology Translational Research, Division of Pediatric Infectious Diseases, Minneapolis, Minnesota, USA.
Craig J
0000-0002-7890-7409
CJ
Bierle
Center for Infectious Diseases and Microbiology Translational Research, Division of Pediatric Infectious Diseases, Minneapolis, Minnesota, USA.
Elizabeth C
EC
Swanson
Center for Infectious Diseases and Microbiology Translational Research, Division of Pediatric Infectious Diseases, Minneapolis, Minnesota, USA.
Claudia
C
Fernández-Alarcón
Department of Pediatrics, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
Nelmary
N
Hernandez-Alvarado
Center for Infectious Diseases and Microbiology Translational Research, Division of Pediatric Infectious Diseases, Minneapolis, Minnesota, USA.
Jason C
JC
Zabeli
Center for Infectious Diseases and Microbiology Translational Research, Division of Pediatric Infectious Diseases, Minneapolis, Minnesota, USA schleiss@umn.edu.
Mark R
MR
Schleiss
D000818:Animals; D001835:Body Weight; D022202:Chromosomes, Artificial, Bacterial; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000473:pathology* / Q000821:virology; D004195:Disease Models, Animal; D004926:Escherichia coli / Q000235:genetics; D005347:Fibroblasts / Q000821:virology*; D006023:Glycoproteins / Q000235:genetics; D006168:Guinea Pigs; D009154:Mutation; D055503:Protein Multimerization; D019211:Roseolovirus / Q000235:genetics* / Q000254:growth & development / Q000472:pathogenicity*; D017384:Sequence Deletion; D012692:Serial Passage; D019562:Viral Load; D015678:Viral Structural Proteins / Q000235:genetics; D014766:Viremia; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics
D006023:Glycoproteins; D015678:Viral Structural Proteins; D037521:Virulence Factors